Thioredoxin: a key factor in cold tumor formation and a promising biomarker for immunotherapy resistance in NSCLC by Jiayi Hu, Yilimunuer Abulimiti, Haiyang Wang, Dianyu Yang, Xu Wang, Yang Wang, Ping Ji

Subjects: “…Immune checkpoint Blockade (ICB) therapy…”
Get full text

Elevated THOC5 expression in liver cancer and its implications for tumor progression and therapeutic response by Jin-Shu Pang, Jin-Shu Pang, Yu Yang, Yu Yang, Li Liang, Yu-Jia Zhao, Jin-Dan Li, Li-Peng Li, Xue-Xin Wei, Rui-Zhi Gao, Rong Wen, Yun He, Hong Yang, Hong Yang, Hong Yang, Xiu-Mei Bai, Xiu-Mei Bai

Subjects: Get full text

Editorial: Tumor-associated tertiary lymphoid structures response during immunotherapy by Ileana Soto Mauldin, Christine Mall Minnar, Antoine Italiano, Antoine Italiano

Subjects: “…checkpoint blockade (ICB) therapy…”
Get full text

Tissue‐Resident Memory CD8+ T Cells: Differentiation, Phenotypic Heterogeneity, Biological Function, Disease, and Therapy by Luming Xu, Lilin Ye, Qizhao Huang

Subjects: Get full text

Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1 by Xin Zang, Xiao-Yu He, Cheng-Mei Xiao, Qing Lin, Meng-Yue Wang, Cheng-Yan Liu, Ling-Yi Kong, Zhong Chen, Yuan-Zheng Xia

Subjects: Get full text